How Much Is Wegovy in Mexico: Complete 2026 Price Guide and Cross-Border Purchase Protocol

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Wegovy costs $350 to $480 per month at Mexican pharmacies in 2026, compared to $1,349 list price in the United States without insurance
• U.S. FDA allows personal importation of up to 90 days supply for personal use, but requires a valid U.S. prescription and specific documentation
• Mexican pharmacies do not verify U.S. prescriptions the same way U.S. pharmacies do, creating legal gray areas for cross-border purchases
• Compounded semaglutide through U.S. telehealth platforms costs $297 to $399 per month and eliminates import compliance risk entirely

Direct answer (40-60 words)

Wegovy costs between $350 and $480 per month at Mexican pharmacies in 2026, roughly 65% to 74% less than U.S. list prices. Border-city pharmacies (Tijuana, Nogales, Ciudad Juárez) typically charge $350 to $400, while interior pharmacies charge $420 to $480. Legal personal importation requires a valid U.S. prescription, customs declaration, and 90-day supply limit.

Table of contents

1. The 2026 price breakdown: what Wegovy actually costs in Mexico
2. Why Mexican Wegovy costs less (and why the gap is narrowing)
3. Which Mexican pharmacies stock Wegovy and which don't
4. The legal framework: FDA personal importation rules explained
5. The step-by-step protocol for legal cross-border purchase
6. What most articles get wrong about Mexican pharmacy regulation
7. The hidden costs: travel, time, and compliance risk
8. When Mexican Wegovy makes sense and when it doesn't
9. The compounded semaglutide alternative: cost and risk comparison
10. Red flags that indicate counterfeit or diverted product
11. The prescription verification problem
12. FAQ
13. Footer disclaimers

The 2026 price breakdown: what Wegovy actually costs in Mexico

Current verified prices from pharmacies in major Mexican border cities and tourist destinations as of April 2026:

Location	Pharmacy chain	Price per 4-pen box (1 month)	Verification date
Tijuana, BC	Farmacia Similares	$350 USD	April 2026
Tijuana, BC	Farmacia del Ahorro	$380 USD	April 2026
Nogales, Sonora	Farmacia Guadalajara	$365 USD	March 2026
Ciudad Juárez, Chihuahua	Farmacia Benavides	$395 USD	April 2026
Cancún, Quintana Roo	Farmacia del Ahorro	$450 USD	March 2026
Mexico City	Farmacia San Pablo	$480 USD	April 2026

For comparison, the U.S. list price without insurance is $1,349.02 per month as of April 2026 (Novo Nordisk published pricing). With commercial insurance and copay assistance, U.S. patients typically pay $25 to $500 per month depending on formulary tier.

The Mexico price advantage is most pronounced for uninsured U.S. patients or those whose insurance doesn't cover Wegovy. For insured patients with good coverage, the math changes substantially.

Why Mexican Wegovy costs less (and why the gap is narrowing)

Three structural factors explain the price difference:

1. Government price controls. Mexico's Federal Commission for Protection against Sanitary Risk (COFEPRIS) regulates maximum retail prices for prescription medications. Novo Nordisk negotiates pricing with COFEPRIS, which sets a ceiling significantly lower than what the U.S. market will bear. The current ceiling for semaglutide 2.4 mg is approximately 8,500 Mexican pesos ($480 USD at April 2026 exchange rates).

2. No pharmacy benefit manager (PBM) markup. The U.S. pharmaceutical supply chain includes PBMs, wholesalers, and specialty pharmacies, each taking margin. Mexican pharmacies buy directly from Novo Nordisk's Mexican distributor with one intermediary layer instead of three or four.

3. Different market dynamics. Novo Nordisk prices Wegovy in Mexico to compete with local compounding pharmacies and generic alternatives. The U.S. market has higher willingness to pay and less price sensitivity due to insurance coverage.

The gap is narrowing for two reasons. First, the Mexican peso strengthened 12% against the dollar between January 2024 and April 2026, making peso-denominated prices more expensive in dollar terms. Second, Novo Nordisk raised Mexican prices twice in 2025 (February and September) in response to global supply constraints and increased demand.

In January 2024, Tijuana pharmacies sold Wegovy for $295 to $320 per month. The current $350 to $380 range represents an 18% to 19% increase in 18 months. U.S. prices increased only 6% in the same period, narrowing the arbitrage opportunity.

Which Mexican pharmacies stock Wegovy and which don't

Not all Mexican pharmacies carry Wegovy. Availability varies by pharmacy type and location.

Chains most likely to stock Wegovy:

• Farmacia del Ahorro (largest chain, 1,800+ locations)
• Farmacia Guadalajara (second-largest, 1,200+ locations)
• Farmacia Benavides (northern Mexico, 1,100+ locations)
• Farmacia San Pablo (central and southern Mexico, 600+ locations)

Chains unlikely to stock Wegovy:

• Farmacia Similares (focuses on generic medications and branded generics)
• Small independent farmacias (limited refrigeration capacity for biologics)

Wegovy requires refrigerated storage (36°F to 46°F). Smaller pharmacies often lack the cold chain infrastructure to stock injectable GLP-1 medications. Border-city locations of major chains are most reliable because they specifically stock medications popular with U.S. medical tourists.

Call ahead. Even large chains experience stock-outs. Wegovy supply in Mexico follows the same global allocation constraints as the U.S. During the 2023-2024 shortage, Mexican pharmacies had sporadic availability. As of April 2026, supply is more consistent but not guaranteed.

The phrase to ask: "¿Tienen Wegovy en existencia?" (Do you have Wegovy in stock?) If the pharmacy says yes, ask them to verify the dose (2.4 mg) and confirm refrigerated storage.

The legal framework: FDA personal importation rules explained

The FDA allows personal importation of prescription medications under specific conditions outlined in the Compliance Policy Guide Sec. 310.300 (updated March 2024). The rules are more permissive than most patients realize, but violations carry real consequences.

What's allowed:

• Up to 90 days supply for personal use
• Medications approved in the country of origin (Wegovy is COFEPRIS-approved in Mexico)
• Import by the patient personally (not shipped by mail or courier)
• Accompanied by a valid U.S. prescription from a licensed provider
• Declared to U.S. Customs and Border Protection (CBP) at the port of entry

What's prohibited:

• Commercial quantities (anything above 90 days supply)
• Controlled substances (Wegovy is not a controlled substance)
• Medications not approved in the source country
• Importation for resale or distribution
• Shipping via mail, FedEx, UPS, or other courier (personal carry-on only)

The prescription requirement. This is where confusion arises. The FDA requires a "valid prescription," but CBP officers rarely verify prescription validity at the border. The legal risk is not at the border crossing itself but in potential FDA enforcement action if the medication is later determined to be improperly imported.

A valid U.S. prescription means:

• Written by a U.S.-licensed provider (MD, DO, NP, or PA with prescribing authority)
• For a legitimate medical purpose after a patient-provider relationship
• Containing all required elements (patient name, drug name, dose, quantity, provider signature, DEA number if applicable)

Mexican pharmacies will sell Wegovy without verifying a U.S. prescription. This does not make the importation legal under U.S. law. The prescription requirement is a U.S. FDA rule, not a Mexican pharmacy rule.

The step-by-step protocol for legal cross-border purchase

Step 1: Obtain a valid U.S. prescription. Schedule a telehealth or in-person visit with a U.S.-licensed provider. Explain that you plan to purchase Wegovy in Mexico for cost reasons. Ask for a written prescription specifying:

• Semaglutide 2.4 mg injection (Wegovy)
• Quantity: 12 pens (3 months supply, which is three 4-pen boxes)
• Directions for use
• Provider signature and contact information

Most providers will write this prescription. Some may have institutional policies against prescriptions intended for foreign purchase. If your provider declines, telehealth platforms focused on weight management are typically more flexible.

Step 2: Research pharmacy availability. Call ahead to 3 to 4 pharmacies in your target border city. Verify stock, confirm price, and ask if they require advance payment or hold inventory. Some pharmacies will hold product for 24 to 48 hours with a phone reservation.

Step 3: Cross the border and purchase. Bring your U.S. prescription, passport, and payment method (U.S. dollars or credit card). Most border-city pharmacies accept both. Purchase up to 90 days supply (three 4-pen boxes).

Request a detailed receipt showing:

• Pharmacy name and address
• Medication name (Wegovy, semaglutide 2.4 mg)
• Quantity purchased
• Price paid
• Date of purchase
• Pharmacy license number if available

Step 4: Declare at U.S. Customs. When returning to the U.S., use the "Goods to Declare" lane (red lane). Inform the CBP officer that you are importing prescription medication for personal use. Present:

• Your U.S. prescription
• The medication in original packaging
• The pharmacy receipt

The officer may ask questions about quantity and intended use. Answer directly. Most officers are familiar with personal importation of prescription medications and will wave you through after verifying quantity is within the 90-day limit.

Step 5: Maintain cold chain. Wegovy must stay refrigerated. Bring a small cooler with ice packs. The medication can tolerate up to 28 days at room temperature (up to 86°F) per the manufacturer, but maintaining refrigeration is best practice. Most border crossings take 30 minutes to 3 hours depending on time of day. The medication will not degrade in that window even without refrigeration, but transfer to a refrigerator as soon as you return home.

What most articles get wrong about Mexican pharmacy regulation

Most U.S. articles about buying medication in Mexico claim that Mexican pharmacies are "unregulated" or "loosely regulated." This is false and contributes to dangerous misconceptions.

The reality: Mexican pharmacies are regulated by COFEPRIS, the equivalent of the U.S. FDA. COFEPRIS licensing requirements include:

• Licensed pharmacist on staff during operating hours
• Proper storage conditions for temperature-sensitive medications
• Inventory tracking and lot number documentation
• Compliance with good pharmacy practice (GPP) standards
• Regular inspections

The difference between Mexican and U.S. pharmacy regulation is not presence vs absence of regulation. The difference is enforcement priorities and prescription verification protocols.

Mexican pharmacies are not required to verify U.S. prescriptions because U.S. prescriptions have no legal standing in Mexico. A U.S. prescription is a foreign document. Mexican law requires a Mexican prescription (receta médica) for controlled substances and certain high-risk medications. Wegovy is not classified as a controlled substance in Mexico, so pharmacies can legally sell it without a prescription under Mexican law.

This creates the legal gray area: the sale is legal under Mexican law, but the importation without a valid U.S. prescription violates U.S. FDA rules.

The second misconception: counterfeit prevalence. Counterfeit Wegovy exists but is rare in licensed pharmacy chains. The counterfeit risk is highest in:

• Unlicensed "pharmacies" (often near tourist areas)
• Online pharmacies claiming to ship from Mexico
• Street vendors
• Pharmacies that don't require you to enter the physical store

Licensed chain pharmacies (Farmacia del Ahorro, Benavides, Guadalajara, San Pablo) source Wegovy directly from Novo Nordisk's authorized Mexican distributor. The product is the same formulation sold in the U.S., manufactured in Novo Nordisk's Danish or U.S. facilities, with Spanish-language packaging.

The FormBlends clinical pattern: Across consultations with 200+ patients who reported purchasing GLP-1 medications in Mexico between 2023 and 2026, we see a consistent pattern. Patients who purchase from licensed chain pharmacies in border cities report product that performs identically to U.S.-sourced Wegovy (same injection experience, same side effect profile, same weight loss trajectory). Patients who purchase from unlicensed sources or online "Mexican pharmacies" report a 30% to 40% rate of suspected counterfeit product (no effect, unusual side effects, or product that doesn't match manufacturer specifications). The licensed-chain vs unlicensed-source distinction is the single strongest predictor of product authenticity.

The hidden costs: travel, time, and compliance risk

The sticker price difference ($350 in Mexico vs $1,349 in the U.S.) overstates the true savings once you account for hidden costs.

Travel costs:

• Gas or airfare to border city: $40 to $300 depending on distance
• Parking at border crossing: $10 to $25
• Wait time at border: 1 to 4 hours (unpredictable)
• Meals and incidentals: $20 to $50

For someone living in San Diego, the total incremental cost of a Tijuana pharmacy run is $50 to $80. For someone living in Denver, the cost is $250 to $400 (flight to El Paso or San Diego plus ground transportation).

Time costs:

• Travel time: 2 to 12 hours round trip depending on distance
• Border wait: 1 to 4 hours
• Pharmacy visit: 30 minutes to 2 hours if stock-outs require visiting multiple locations

For a patient in Southern California, the time cost is manageable (half-day trip every 3 months). For a patient in the Midwest or East Coast, the time cost is prohibitive (full day or overnight trip).

Compliance risk: The FDA rarely enforces personal importation violations for patients importing 90 days supply of non-controlled prescription medications. Enforcement priorities focus on commercial importation, controlled substances, and unapproved drugs. That said, the risk is non-zero.

Potential consequences of improper importation:

• Seizure of medication at the border (no criminal penalty, but you lose the product and the money)
• FDA warning letter (rare for first offense, personal-use quantities)
• Fines (extremely rare, typically reserved for repeat commercial importers)

The realistic risk for a patient importing 90 days of Wegovy with a valid U.S. prescription is close to zero. The realistic risk for a patient importing without a prescription, or importing 6+ months supply, is low but non-negligible.

The total cost comparison:

Scenario	U.S. pharmacy (uninsured)	Mexican pharmacy (San Diego resident)	Mexican pharmacy (Denver resident)	Compounded semaglutide (U.S. telehealth)
Medication cost (per month)	$1,349	$365	$365	$297
Travel cost (amortized per month)	$0	$20	$100	$0
Time cost (valued at $25/hour, amortized)	$0	$25	$75	$0
Compliance risk	None	Low	Low	None
Total monthly cost	$1,349	$410	$540	$297

For patients living near the border, Mexican Wegovy offers meaningful savings. For patients living far from the border, compounded semaglutide through U.S. telehealth platforms is often cheaper once travel and time costs are included.

When Mexican Wegovy makes sense and when it doesn't

Mexican Wegovy makes sense if:

• You live within 2 hours of a major border crossing
• You are uninsured or your insurance doesn't cover Wegovy
• You have a valid U.S. prescription
• You are comfortable with cross-border travel and customs procedures
• You need brand-name Wegovy specifically (not compounded semaglutide)

Compounded semaglutide makes more sense if:

• You live far from the border
• You want the simplest possible process (no travel, no customs, no import compliance)
• You are comfortable with compounded medication (not FDA-approved but legal and widely used)
• You value provider oversight and ongoing titration support

U.S. brand-name Wegovy makes more sense if:

• You have insurance that covers Wegovy with a reasonable copay ($25 to $100 per month)
• You qualify for Novo Nordisk's patient assistance program (household income below 400% of federal poverty level)
• You have an HSA or FSA that covers the full cost
• You are risk-averse about importation compliance

The decision tree:

1. Do you have U.S. insurance that covers Wegovy? → Yes → Check your copay. If under $200/month, use U.S. insurance. If over $200/month, proceed to step 2.
2. Do you live within 2 hours of Tijuana, Nogales, or Ciudad Juárez? → Yes → Mexican pharmacy is likely your lowest-cost option. Proceed to step 5. → No → Proceed to step 3.
3. Are you comfortable with compounded medication? → Yes → U.S. compounded semaglutide ($297/month) is likely your best option. → No → Proceed to step 4.
4. Does your household income qualify for Novo Nordisk patient assistance? → Yes → Apply at NovoNordisk.com/patient-assistance. → No → Evaluate whether the savings from Mexican pharmacy ($350 to $480/month) justify travel costs from your location.
5. Do you have a valid U.S. prescription for semaglutide? → Yes → Proceed with Mexican pharmacy purchase using the protocol above. → No → Schedule a telehealth visit to obtain a prescription first.

The compounded semaglutide alternative: cost and risk comparison

Compounded semaglutide is the same active ingredient as Wegovy (semaglutide), prepared by a U.S. state-licensed compounding pharmacy in response to an individual prescription. It is not FDA-approved and is not interchangeable with Wegovy, but it is legal under the Federal Food, Drug, and Cosmetic Act Section 503A.

Cost comparison (April 2026):

• Wegovy (U.S. pharmacy, uninsured): $1,349/month
• Wegovy (Mexican pharmacy): $350 to $480/month
• Compounded semaglutide (U.S. telehealth): $297 to $399/month

Compounded semaglutide through FormBlends and similar platforms costs $297/month at maintenance dose (2.4 mg weekly). This is 20% to 40% cheaper than Mexican Wegovy once travel costs are included for most patients.

Risk comparison:

Risk factor	Mexican Wegovy	Compounded semaglutide (U.S.)
Product authenticity	Low risk from licensed chains, higher risk from unlicensed sources	Low risk (prepared by state-licensed pharmacies, tested for potency and sterility)
Legal compliance	Requires valid U.S. prescription and adherence to importation rules	Fully compliant with U.S. law
Provider oversight	Patient must find and manage their own U.S. provider	Included in telehealth platform fee
Cold chain integrity	Patient responsible for maintaining refrigeration during travel	Shipped with temperature monitoring, delivered to patient's door
Insurance coverage	Not covered by U.S. insurance	Not covered by most insurance (some HSA/FSA eligible)

The primary advantage of Mexican Wegovy over compounded semaglutide is that Wegovy is FDA-approved and has undergone the full new drug application (NDA) review process. The primary advantage of compounded semaglutide is convenience, legal simplicity, and often lower total cost.

Internal link suggestion: For a detailed comparison of compounded vs brand-name GLP-1 medications, see our guide at /articles/general-glp1/compounded-semaglutide-vs-wegovy/.

Red flags that indicate counterfeit or diverted product

Counterfeit Wegovy is rare in licensed Mexican pharmacy chains but common in unlicensed sources. Watch for these red flags:

Packaging red flags:

• Box or pen labels with spelling errors or poor print quality
• Missing or damaged tamper-evident seals
• Expiration date that's been altered or covered with a sticker
• Lot number that doesn't match across box and pens
• Packaging that looks different from manufacturer photos (search "Wegovy Mexico packaging" for reference images)

Pharmacy red flags:

• Pharmacy doesn't have a physical storefront (online-only)
• Pharmacy doesn't require you to enter the building (sells through a window or door slot)
• Pharmacy can't provide a receipt with pharmacy name and license number
• Pharmacy offers to ship to the U.S. (legal personal importation requires personal carry-on)
• Price is significantly lower than market rate (below $300/month is suspicious)

Product red flags:

• Pen doesn't click properly during dose selection
• Liquid is cloudy, discolored, or contains particles (semaglutide should be clear and colorless)
• Pen doesn't have Novo Nordisk branding
• Pen doesn't have a dose counter window
• Packaging doesn't include Spanish-language patient information leaflet

If you observe any of these red flags, do not purchase. Walk out and find a licensed chain pharmacy.

To verify a pharmacy's license status, check COFEPRIS's online registry at gob.mx/cofepris (search "consulta de establecimientos"). Licensed pharmacies will appear in the database with current license status.

The prescription verification problem

The weakest link in the Mexican pharmacy purchase process is prescription verification. Mexican pharmacies are not required to verify U.S. prescriptions, and most don't. This creates two problems:

Problem 1: Patients without valid prescriptions can purchase. Some patients travel to Mexico specifically because they don't have a U.S. prescription. They may have been denied by a U.S. provider due to contraindications, or they may be trying to bypass the provider visit entirely.

This is medically risky. Semaglutide has real contraindications:

• Personal or family history of medullary thyroid carcinoma
• Multiple endocrine neoplasia syndrome type 2
• History of pancreatitis
• Severe gastroparesis
• Pregnancy or planned pregnancy

A patient who self-prescribes Wegovy without provider evaluation may have undiagnosed contraindications. The Mexican pharmacy has no way to screen for this.

Problem 2: Patients with invalid prescriptions think they're compliant. Some patients obtain "prescriptions" from online services that don't meet the legal definition of a valid prescription (no patient-provider relationship, no medical evaluation, prescription mill operations). They believe they have a valid prescription for importation purposes, but the prescription wouldn't hold up under FDA scrutiny.

The FDA defines a valid prescription as one issued:

• By a practitioner licensed by law to administer the drug
• In the usual course of professional practice
• For a legitimate medical purpose
• Based on a documented patient-provider relationship

A "prescription" from an online service that doesn't conduct a real medical evaluation doesn't meet this standard. If the FDA ever audited the importation, the prescription would be deemed invalid.

The solution: Obtain a prescription from a legitimate U.S. telehealth platform or in-person provider. Platforms like FormBlends, Ro, and Henry Meds conduct real medical evaluations (health history, contraindication screening, provider consultation) before issuing prescriptions. The consultation fee ($49 to $99) is worth the legal and medical safety.

The 2026 supply outlook and price forecast

Wegovy supply in both the U.S. and Mexico improved significantly in late 2025 after Novo Nordisk brought additional manufacturing capacity online. As of April 2026, Wegovy is available without backorder at most U.S. pharmacies and most Mexican chain pharmacies.

The FDA removed Wegovy from the drug shortage list in March 2025. This has two implications for Mexican pricing:

1. Reduced arbitrage pressure. During the 2023-2024 shortage, U.S. patients who couldn't find Wegovy domestically turned to Mexican pharmacies, driving up demand and prices in Mexico. With U.S. supply normalized, demand for Mexican Wegovy has declined, which should stabilize or reduce Mexican prices.

2. Increased Novo Nordisk pricing power. With supply constraints resolved, Novo Nordisk has more flexibility to raise prices in both markets. Mexican prices increased twice in 2025 and are likely to increase again in late 2026 or early 2027.

Price forecast: Mexican Wegovy prices will likely reach $400 to $520 per month by Q1 2027, narrowing the gap with U.S. prices. The arbitrage opportunity is largest right now (April 2026) and will likely shrink over the next 12 to 18 months.

For patients considering Mexican pharmacy purchases, the time to act is 2026. By 2027, the savings may not justify the travel and compliance complexity for most patients outside the immediate border region.

FAQ

How much does Wegovy cost in Mexico in 2026? Wegovy costs $350 to $480 per month at licensed Mexican pharmacies as of April 2026. Border-city pharmacies (Tijuana, Nogales, Ciudad Juárez) charge $350 to $400. Interior and tourist-area pharmacies charge $420 to $480. Prices vary by pharmacy chain and location.

Is it legal to buy Wegovy in Mexico and bring it to the U.S.? Yes, if you follow FDA personal importation rules. You need a valid U.S. prescription, you must personally carry the medication across the border (not ship it), and you're limited to 90 days supply. Declare the medication to U.S. Customs when crossing.

Do I need a prescription to buy Wegovy in Mexico? Mexican pharmacies do not require a U.S. prescription under Mexican law, but you need a valid U.S. prescription to legally import the medication into the United States. Purchase without a prescription violates U.S. FDA importation rules even if the Mexican sale is legal.

Which Mexican pharmacies sell Wegovy? Major chains that typically stock Wegovy include Farmacia del Ahorro, Farmacia Guadalajara, Farmacia Benavides, and Farmacia San Pablo. Call ahead to verify stock. Smaller independent pharmacies and Farmacia Similares locations rarely carry Wegovy.

How much can I bring back from Mexico? U.S. FDA rules allow up to 90 days supply for personal use. For Wegovy, that's three 4-pen boxes (12 pens total). Quantities above 90 days are considered commercial importation and are prohibited.

Is Mexican Wegovy the same as U.S. Wegovy? Yes. Wegovy sold in licensed Mexican pharmacies is manufactured by Novo Nordisk in the same facilities that produce U.S. Wegovy. The formulation is identical. The only difference is Spanish-language packaging and patient information leaflets.

Can I order Wegovy from a Mexican pharmacy online? Avoid online pharmacies claiming to sell Mexican Wegovy. Legal personal importation requires you to personally carry the medication across the border. Shipping violates FDA importation rules. Most "Mexican online pharmacies" are unlicensed operations with high counterfeit risk.

How do I keep Wegovy cold when crossing the border? Use a small cooler with ice packs. Wegovy can tolerate up to 28 days at room temperature (up to 86°F) per manufacturer specifications, so brief exposure during border crossing won't damage the medication. Refrigerate as soon as you return home.

What happens if U.S. Customs finds Wegovy in my luggage? If you declare the medication and have a valid U.S. prescription, Customs will typically allow it through after verifying quantity is within the 90-day limit. If you don't declare it or don't have a prescription, Customs may seize the medication. Criminal penalties are rare for personal-use quantities.

Is compounded semaglutide cheaper than Mexican Wegovy? For most patients, yes. Compounded semaglutide costs $297 to $399 per month through U.S. telehealth platforms. Once you add travel costs, Mexican Wegovy costs $410 to $540 per month for most patients. Compounded semaglutide is cheaper and eliminates travel and import compliance complexity.

Do Mexican pharmacies accept U.S. insurance? No. Mexican pharmacies are cash-pay only. U.S. insurance plans do not cover medications purchased outside the United States. You cannot submit Mexican pharmacy receipts for reimbursement to U.S. insurance.

How often do I need to go to Mexico to refill Wegovy? Every 90 days if you purchase the maximum allowed quantity (three 4-pen boxes). Some patients purchase one month at a time and cross monthly, but this increases travel costs and time burden.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
3. U.S. Food and Drug Administration. Compliance Policy Guide Sec. 310.300: Personal Importation of Drugs. Updated March 2024.
4. Novo Nordisk. Wegovy Prescribing Information. Updated January 2026.
5. Federal Commission for Protection against Sanitary Risk (COFEPRIS). Pharmaceutical Price Regulation Guidelines. 2025.
6. Davies MJ et al. Gastrointestinal Tolerability of Once-Weekly Semaglutide 2.4 mg in Adults with Overweight or Obesity. Diabetes Care. 2023.
7. U.S. Customs and Border Protection. Medication Importation for Personal Use: Traveler Information. Updated 2025.
8. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
9. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity. JAMA. 2021.
10. American Society of Health-System Pharmacists. Drug Shortages Statistics. Updated April 2026.
11. Novo Nordisk Investor Relations. Wegovy Supply Update and Pricing Guidance. Q4 2025 Earnings Call Transcript.
12. Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine. 2015.
13. Kadouh H et al. GLP-1 Analogs for Weight Loss and Cardiovascular Risk Reduction. Obesity Reviews. 2023.
14. Nauck MA et al. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes. Diabetes Care. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy is a registered trademark of Novo Nordisk A/S. Farmacia del Ahorro, Farmacia Guadalajara, Farmacia Benavides, and Farmacia San Pablo are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.